Je Moon Yoon, MD, investigated the association between rheumatoid arthritis and the risk of retinal vein occlusion and ...

Key Takeaways from the Retinal Vein Occlusion Pipeline Report In May 2025, Bayer conducted a study treatment intravitreal (IVT) aflibercept is given as an injection into the eye.

Investigators evaluated the association between extended faricimab dosing and early macular leakage area resolution in ...

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

Song P, et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019; 9:010427.

Retinal vein occlusion (RVO) is a significant retinal vascular disorder that can lead to severe visual impairment. Recent research suggests that vitamin D may play a crucial role in preventing and ...

Pvt Ltd has been directed by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) to ...

Retinal vein occlusion: New eye drops may prevent this common cause of blindness Researchers say that these eye drops may offer several advantages over existing therapies. @Shutterstock ...

Retinal Vein Occlusion Epidemiology The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of RVO, Diagnosed ...

The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the ...

Global retinal vein occlusion treatment market to reach a valuation of US$ 4.7 billion in 2033 East Asia retinal vein occlusion market is expected to expand at a CAGR of 6.5%. From 2018 to 2022 ...